Preoperative Osteopenia Is Associated with Significantly Shorter Survival in Patients with Perihilar Cholangiocarcinoma

Simple Summary Perihilar cholangiocarcinoma is an infrequent and advanced hepatobiliary neoplasm with a generally poor prognosis. Surgical treatment is the only curative therapy that offers the promise of long-term survival. The identification of risk factors and appropriate treatment strategies are essential to improve long-term survival. Osteopenia is defined as low bone mineral density and has been shown to be associated with outcomes of patients with various cancers. The association between osteopenia and perihilar cholangiocarcinoma is unknown. This is the first report to show that osteopenia is associated with shorter survival in patients with perihilar cholangiocarcinoma. Preoperative osteopenia may be a useful tool for predicting prognosis in patients with perihilar cholangiocarcinoma. Background: Osteopenia is defined as low bone mineral density (BMD) and has been shown to be associated with outcomes of patients with various cancers. The association between osteopenia and perihilar cholangiocarcinoma is unknown. The aim of this study was to evaluate osteopenia as a prognostic factor in patients with perihilar cholangiocarcinoma. Methods: A total of 58 patients who underwent surgery for perihilar cholangiocarcinoma were retrospectively analyzed. The BMD at the 11th thoracic vertebra was measured using computed tomography scan within one month of surgery. Patients with a BMD < 160 HU were considered to have osteopenia and b BMD >= 160 did not have osteopenia. The log-rank test was performed for survival using the Kaplan-Meier method. After adjusting for confounding factors, overall survival was assessed by Cox ' s proportional-hazards model. Results: The osteopenia group had 27 (47%) more females than the non-osteopenia group (p = 0.036). Median survival in the osteopenia group was 37 months and in the non-osteopenia group was 61 months (p = 0.034). In multivariable analysis, osteopenia was a significant independent risk factor associated with overall survival in patients with perihilar cholangiocarcinoma (hazard ratio 3.54, 95% confidence interval 1.09-11.54, p = 0.036), along with primary tumor stage. Conclusions: Osteopenia is associated with significantly shorter survival in patients with perihilar cholangiocarcinoma.

Automated summary

This study aimed to evaluate whether osteopenia is a prognostic factor in patients with perihilar cholangiocarcinoma. The study found that osteopenia is associated with significantly shorter survival in patients with perihilar cholangiocarcinoma, and preoperative osteopenia may be a useful tool for predicting prognosis in these patients.